Treatment of seasonal allergic rhinitis in patients ≥6 years old and perennial allergic rhinitis in patients ≥12 years old. Omnaris is an alcohol-free, hypotonic suspension formulation of the ...

A Canadian real-world study reveals high oral corticosteroid exposure in patients with severe chronic rhinosinusitis with ...

Dupilumab, a fully human monoclonal antibody, inhibits the signaling of the interleukin 4 (IL-4) and IL-13 pathways.

Ottawa, Nov. 20, 2025 (GLOBE NEWSWIRE) -- The global intranasal corticosteroids market size was valued at USD 7.22 billion in 2024 and is predicted to hit around USD 11.57 billion by 2034, rising at a ...

People who have been regularly using steroid nasal sprays before getting COVID-19 are less likely to develop severe cases, according to new data. But Cleveland Clinic researchers emphasized that their ...

Regular use of steroid nasal sprays afforded COVID-19 patients protection against virus-related hospitalization, ICU admission and death, the Cleveland Clinic announced Tuesday. However, the findings ...

Please provide your email address to receive an email when new articles are posted on . Sinusitis-related quality of life might improve with intranasal corticosteroid rinse and exhalation delivery ...

People who regularly use steroid nasal sprays may have a lower risk of severe disease from a COVID-19 infection, according to research recently published in Journal of Allergy and Clinical Immunology: ...

Medically reviewed by Sukaina Hasnie, MD Key Takeaways Nasal sprays can help treat congestion and other symptoms from ...

The approval was based on data from the phase 3 SYNAPSE study that evaluated mepolizumab as an add-on maintenance treatment in over 400 adults with CRSwNP. The Food and Drug Administration (FDA) has ...

NEW YORK (Reuters Health) - The corticosteroid drug budesonide, given as a nasal spray for 6 weeks, benefits children with mild sleep apnea, a study shows. Obstructive sleep apnea occurs when soft ...